Topic

Articles

With treatments becoming more complex, the life sciences industry needs more professionals with specialized knowledge.

Why Medical Engagement With Key Opinion Leaders Drives Treatment Adoption: Q&A with Dan Rizzo, global head of Veeva business consulting 

Mike Hollan is an assistant managing editor for 

 and can be reached at mhollan@mjhlifesciences.com.

Embrace the tools that solve real problems and make life easier.

Find the Solutions That People are Actually Asking for

Eager to Educate

Meg Rivers is the former managing editor of 

One of the most special things about Pharmaceutical Executive®, in my opinion, is when people share their stories—where they came from; how their upbringing or education or background impacted their desire to work in pharma; any personal ties to their work, such as finding new treatments in a specific disease state due to a loved one having been impacted by that same disease; and just generally sharing their passion for their work. As someone who’s worked in pharma journalism for many years, there’s something extraordinary to hear about the why for individuals. 

The Stories That Shine

Miranda Schmalfuhs is the associate group social media editor of 

Pharmaceutical Executive, Pharmaceutical Commerce

 and can be reached at mschmalfuhs@mjhlifesciences.com.

In this Q&A, Matt Smith, vice president of research site development, Slope, discusses the competition pharma companies and trial sponsors face when trying to become a sponsor of choice and build trust with sites and patients. 

How to Become a Sponsor of Choice

Here in New Jersey, our home base, summer is officially upon us, and the Canadian wildfire smoke has just cleared from the air. I’m sure the bird watchers would attest to the eager chirping as both wildlife and humans greedily enjoy the beautiful weather. But even as the seasons change, so does the technology that drives innovation, as coverage in the July issue of Pharmaceutical Executive® attests. 

Marketing in the AI Age

AI Heating Up On the Pharma Stage

Petra Jantzer, PhD, is a senior managing director and global life sciences lead at Accenture.

Selen Karaca-Griffin is a senior principal and global life sciences research lead at Accenture.

There are clear pathways that biopharma companies can take to sustain growth and remain competitive.

How Biopharma Can Accelerate Innovation and Sustain Growth

This month, we deliver deep dives into the industry's commercial output and outlook and how drugmakers are faring in their public trust mandate—two areas where respective growth pursuits can often go hand-in-hand.     


Pharma Trends & Trust

As conference season ramps up, it's a good time to reflect on the impact advances in pharma have on patients.